When Pruritus is Not Allergy: Appropriate Signs of Lymphoma and Other Malignancies for the Community Allergist
DOI:
https://doi.org/10.58931/cait.2023.3139Abstract
Pruritus is a common symptom that all individuals have experienced at some time. Although general malignancy is a rare cause of pruritus, there is an increased risk of hematologic malignancy in those with chronic itch. For the allergist assessing chronic itch, we have outlined an approach in the case of suspected hematologic malignancy and steps for an initial work-up.
References
Rademaker M, Thomas RH, Meyrick Lowe DG, Munro DD. Linear streaking due to bleomycin. Clinical and experimental dermatology. 1987;12(6):457-9.
Weisshaar E, Dalgard F. Epidemiology of itch: adding to the burden of skin morbidity. Acta dermato-venereologica. 2009;89(4):339-50.
Matterne U, Strassner T, Apfelbacher CJ, Diepgen TL, Weisshaar E. Measuring the prevalence of chronic itch in the general population: development and validation of a questionnaire for use in large-scale studies. Acta dermato-venereologica. 2009;89(3):250-6.
Matterne U, Apfelbacher CJ, Vogelgsang L, Loerbroks A, Weisshaar E. Incidence and determinants of chronic pruritus: a population-based cohort study. Acta dermato-venereologica. 2013;93(5):532-7.
Polat M, Öztas P, İlhan MN, Yalçin B, Alli N. Generalized Pruritus. American Journal of Clinical Dermatology. 2008;9(1):39-44.
Paul R, Paul R, Jansen CT. Itch and malignancy prognosis in generalized pruritus: A 6-year follow-up of 125 patients. Journal of the American Academy of Dermatology. 1987;16(6):1179-82.
Fett N, Haynes K, Propert KJ, Margolis DJ. Five-year malignancy incidence in patients with chronic pruritus: A population-based cohort study aimed at limiting unnecessary screening practices. Journal of the American Academy of Dermatology. 2014;70(4):651-8.
Tuckett RP, Wei JY. Response to an itch-producing substance in cat. II. Cutaneous receptor populations with unmyelinated axons. Brain Research. 1987;413(1):95-103.
Greaves MW. Recent advances in pathophysiology and current management of itch. ANNALS-ACADEMY OF MEDICINE SINGAPORE. 2007;36(9):788.
Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nature Immunology. 2004;5(7):752-60.
Ishii T, Wang J, Zhang W, Mascarenhas J, Hoffman R, Dai Y, et al. Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders. Blood. 2009;113(23):5942-50.
Gobbi PG, Attardo-Parrinello G, Lattanzio G, Rizzo SC, Ascari E. Severe pruritus should be a B-symptom in Hodgkin’s disease. Cancer. 1983;51(10):1934-6.
Rubenstein M, Duvic M. Cutaneous manifestations of Hodgkin’s disease. International journal of dermatology. 2006;45(3):251-6.
